THE ROLE OF ADJUVANT RADIOTHERAPY IN CARCINOMA OF THE ENDOMETRIUM - RESULTS IN 550 PATIENTS WITH PATHOLOGICAL STAGE-I DISEASE

Citation
C. Irwin et al., THE ROLE OF ADJUVANT RADIOTHERAPY IN CARCINOMA OF THE ENDOMETRIUM - RESULTS IN 550 PATIENTS WITH PATHOLOGICAL STAGE-I DISEASE, Gynecologic oncology (Print), 70(2), 1998, pp. 247-254
Citations number
15
Categorie Soggetti
Oncology,"Obsetric & Gynecology
ISSN journal
00908258
Volume
70
Issue
2
Year of publication
1998
Pages
247 - 254
Database
ISI
SICI code
0090-8258(1998)70:2<247:TROARI>2.0.ZU;2-R
Abstract
Objectives. A retrospective analysis of 550 women with pathological st age I carcinoma of the endometrium who were seen between January 1984 and December 1988 was performed in order to assess the value of adjuva nt radiation therapy. Methods. Two-hundred twenty-eight patients were treated with surgery alone (S); 97 received adjuvant external beam rad iotherapy (S + EXT); 217 received external beam radiotherapy and colpo stats (S + EXT + IC); and 8 patients received only colpostats (S + IC) , Pelvic radiation therapy, usually 40 Gy in 20 fractions, was adminis tered to 94% of patients whose tumors showed greater than 50% myometri al invasion and to 89% of patients with FIGO grade 3 tumors. Colpostat s were used in 40% of patients, the majority of whom had lower uterine segment involvement. Results, The overall survival rate for the whole group using Kaplan-Meier estimates was 84% at 5 years, The 5-year ove rall survival rates for each treatment group, excluding the 5 + IC gro up, were 90% for S alone, 79% for 8 + EXT, and 82% for S + EXT + IC. T he 5-year disease-free survival rates were 84, 77, and 77%, respective ly. Local control rates at 5 years were 93, 94, and 95% in the three t reatment groups, but the patterns of relapse were different. Distant m etastases occurred more frequently among the patients who received adj uvant radiation therapy (36/49, 73%) than among those who did not (4/1 9, 21%). Late toxicity was documented in 66 patients. Twelve patients had EORTC/RTOG grade 3 and 4 complications; all had been treated with S + EXT + IC, FIGO grade (P = 0.009), lower uterine segment involvemen t (P = 0.009), and age (P = 0.03) were significant predictors of worse disease-free survival in a multiple regression analysis. Conclusions. The addition of vaginal vault brachytherapy to external beam radiothe rapy did not appear to improve local cure rates nor survival, but incr eased the incidence of late radiation toxicity. (C) 1998 Academic Pres s.